Home
>
National Drug Code (NDC)
>
Rivastigmine Tartrate
Rivastigmine Tartrate - 60505-3220-0 - (Rivastigmine Tartrate)
Drug Information of Rivastigmine Tartrate
| Product NDC: | 60505-3220 |
| Proprietary Name: | Rivastigmine Tartrate |
| Non Proprietary Name: | Rivastigmine Tartrate |
| Active Ingredient(s): | 1.5 mg/1 & nbsp; Rivastigmine Tartrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Rivastigmine Tartrate
| Product NDC: | 60505-3220 |
| Labeler Name: | Apotex Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091072 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130220 |
Package Information of Rivastigmine Tartrate
| Package NDC: | 60505-3220-0 |
| Package Description: | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (60505-3220-0) > 10 CAPSULE in 1 BLISTER PACK |
NDC Information of Rivastigmine Tartrate
| NDC Code | 60505-3220-0 |
| Proprietary Name | Rivastigmine Tartrate |
| Package Description | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (60505-3220-0) > 10 CAPSULE in 1 BLISTER PACK |
| Product NDC | 60505-3220 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Rivastigmine Tartrate |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20130220 |
| Marketing Category Name | ANDA |
| Labeler Name | Apotex Corp. |
| Substance Name | RIVASTIGMINE TARTRATE |
| Strength Number | 1.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
